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Response to the Letter to the Editor by Roemer and collaborators entitled
‘‘Semiquantitative assessment of synovitis in osteoarthritis on non
contrast-enhanced MRI’’ concerning the article published by Pelletier et al.
entitled ‘‘A new non-invasive method to assess synovitis severity in
relation to symptoms and cartilage volume loss in knee osteoarthritis
patients using MRI’’The letter from Roemer et al. addresses some issues re-
lated to our recent publication1, which have to do with the
development of a non-invasive method of assessing the se-
verity of synovitis in osteoarthritic (OA) patients using MRI
and semi-quantitative scoring methods. There is a general
agreement in the literature that, based on the work done
by our group and others over the last few decades, synovial
inﬂammation plays an important role in OA pathophysiology
and disease symptoms. The recent advances in MR imag-
ing have allowed the development of various methods to
quantify the level of synovitis (synovial thickness)2. Some
methods use contrast enhancement (CE) imaging with
agents such as gadolinium while others do not, taking ad-
vantage of different imaging sequences or a combination
of sequences to improve the visualization of the synovial
membrane3. Both methods have been used in observa-
tional studies and have been successful in providing insight
into the role played by synovitis in OA disease processes
and symptoms.
The letter’s authors appear to favor CE over non-CE MRI
scoring methods based on the fact that ‘‘none of these has
been adequately validated.’’ It is therefore surprising to note
that a number of world renowned investigators, including
some who are co-authors of the letter, have used a non-
CE method with semi-quantitative scoring system to per-
form studies exploring the role of synovitis in disease symp-
toms of knee OA patients2e5. Although the scoring methods
used in these studies were mentioned to have been sub-
jected to some validation procedures, these were not in
line with the suggestion made in Roemer et al.’s letter. No
hard data establishing correlation between the CE and
non-CE enhanced scoring methods was presented, nor
any correlation with histological changes of the synovium.
It is, however, interesting to note that two recent studies
in knee OA patients examining the role of synovitis in the
same patient cohort, one utilizing CE imaging6 and the
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vitis and the level of pain. Therefore, based on these ﬁnd-
ings, it is questionable whether the CE method offers
obvious superiority over non-CE, at least in the context of
these studies.
It is interesting to note that the authors of a recent review
article on MRI and OA3 have acknowledged the fact that
‘‘non-gadolinium sequences can be optimized to assess
synovium.’’ They also mention studies in which the degree
of synovial hypertrophy detected using non-gadolinium se-
quences has been correlated with microscopic synovial in-
ﬂammation7e9. Two of these studies8,9 have also used
T1-weighted sequences.
Another study in knee OA patients has shown a very
good correlation between the degree of synovitis (thick-
ness) seen by CE MRI and the degree of synovial inﬂam-
mation measured by histology10. The same group has
recently shown11 that a good correlation also exists be-
tween the WORMS synovitis score (non-CE imaging) and
the CE MRI score used in their previous study (r¼ 0.54,
P< 0.016). In that context, it is therefore not surprising
that the results from our study1 and the above study10 are
quite similar. In light of these ﬁndings, the statement
made by the letter authors should perhaps be revisited?
The length of the publication (brief report) imposed by the
journal, did not permit all of our data to be included. How-
ever, a pilot study comparing the synovitis score in the re-
gions of interest (ROI) in the absence or presence of CE
( gadolinium) was done in a small number of patients
(n¼ 3). The results showed similar ﬁndings in which
a mean synovial thickness score of 1.08 mm 0.21 was
found for non-CE and 1.21 mm 0.23 for CE.
As mentioned by the letter’s authors, fat-saturated se-
quences allow the prevention of chemical shift artifacts
that can result in tissue signal misregistration12. The chem-
ical shift artifact is proportional to the ratio between the pixel
bandwidth and the frequency shift between water and fat
(224 Hz in a magnetic ﬁeld of 1.5T). The pixel bandwidth
chosen for our sequences was in all cases higher than
224 Hz. Thus, the effect of this artifact was limited to a signal
misregistration of one pixel along the interface of fat tissues.
A second important aspect of the chemical shift is that its
effect is oriented along the direction of the frequency
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(AP), the phase being left-right (LR) to avoid the interfer-
ence with ﬂow artifacts associated with the presence of
the popliteal artery. To ensure the reliability of the readings,
the measurements were done only in the ROI where the sy-
novial membrane could be clearly identiﬁed with respect to
surrounding tissues, e.g., the retinaculum. In all cases, the
synovium was measured on the external wall of the lateral
and medial recesses, thus perpendicularly to the frequency
gradient axis, greatly limiting the impact of chemical shift ar-
tifacts on our measurements. Hence, in the light of these
technical considerations, we believe that the use of non-sat-
urated sequences did not result in signiﬁcant reading arti-
facts. Moreover, we noticed during the preliminary study
that the use of fat saturation in unenhanced sequences
decreases the contrast of the synovial membrane vs the sy-
novial ﬂuid and surrounding soft tissues, thereby limiting the
conspicuity of the synovial membrane and, most impor-
tantly, the accuracy of any quantitative or semi-quantitative
measurement. The combination of the T1 and T2-weighted
sequences used in our study was judged optimal to delin-
eate synovial tissue from synovial ﬂuid.
The authors made additional criticisms regarding the ﬁeld
of view (FOV) used in our study. Mainly, they assumed that
the matrix dimension mentioned in our article (i.e., 320
pixels [ px]) represented the total number of pixels in the im-
age matrix and would therefore indicate a matrix of
17.917.9 px, which we believe is unrealistic to any clinical
sequence used in medicine in our decade. We wish to
clarify that the FOV of the TrueFISP sequence used in
our study was 160 mm for an acquisition matrix of
320320 px which allows square acquisition pixels of
0.5 mm. The FOV of the T1-weighted GRE InPhase/Out-
Phase sequence was 180 mm for an acquisition matrix of
320256 px allowing square acquisition pixels of
0.5625 mm. Using interpolation during image reconstruc-
tion, images at a resolution of 512640 px with square
pixels of 0.28 mm/px were generated and used for the as-
sessment of the synovial membrane. Not only is this read-
ing resolution clearly acceptable, but the acquisition
resolution of our sequences was superior to any of the se-
quences (at best 0.625 mm/px) described in the referenced
publications of Roemer et al.’s letter (letter references 3e6).
The tool used to measure the synovial membrane operates
at a sub-pixel level, enhancing the accuracy and the sensi-
tivity of the reading. We believe that optimal spatial resolu-
tion, as used in our study, is mandatory when structures as
small as the synovial membrane are measured with MRI.
The statistical analysis method used, the non-parametric
Spearman correlation, is one simple way to assess synovial
tissue inﬂammation reliability among and between readers
over time on a semi-quantitative score. These simple corre-
lations of intra and inter-reader reliability of MRI synovitis
reading have previously been used by other investiga-
tors11,13. The excellent correlations demonstrated by our
study compared to others may be related to the fact that
we speciﬁcally measured the synovial thickness in mm us-
ing a software tool and then transposed the value into
a semi-quantitative scale. This strategy may prevent the
reader’s subjective interpretation of differentiating between
a score of, for example, 1 vs 2, and, as such, potentially im-
prove the measurement reliability. We agree, however, that
ICC and Kappa would better reﬂect such agreement among
readers for a semi-quantitative score and further reliability
studies are presently under way. Of importance is that the
developed scoring system demonstrated a great sensitivity
to change of synovitis, even when using a small number ofpatients (n¼ 14). This is of the utmost importance since
measurement of the relative change in the synovial mem-
brane over time is one of the targeted strategies when
one wants to assess the impact of therapeutic intervention
on knee OA.
We encourage a positive and constructive approach to-
ward the use of a non-CE scoring system for many reasons,
some of which are brieﬂy summarized in a recent editorial14,
in which most importantly is the fact that the regulatory
agencies, including the FDA, have issued a warning indicat-
ing that severe and potentially fatal complications can be
induced by gadolinium. Therefore, in the context of clinical
or epidemiological studies that include a large number of
patients and/or in which MRI examinations are done repeat-
edly over time, such as in clinical trials, the use of CE is to
be discouraged. This is not to mention the extra time, cost
and risk to the patients that such CE procedure adds to
the conduct of these studies. The present study represents
one more positive step in the development of a non-CE MRI
synovitis scoring method. However, and this is true for
every new method, it requires corroboration from larger
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